PIKE NEWS
07.11.2026 01:52 UTC · Market News Feed

FDA CONTINUES TO ASSESS NEOPLASIA RISKS, INCLUDING MALIGNANCY, IN SIMILAR AAV GENE THERAPY PROGRAMS

Türkçe

FDA, BENZER AAV GEN TERAPİSİ PROGRAMLARINDA NEOPLAZİ RİSKLERİNİ, MALİGNİTE DAHİL, DEĞERLENDİRMEYE DEVAM EDİYOR.

Breaking crypto & TradFi news, the moment it happens